Advertisement

Restoration of Depressed Antibody Responses of Leukemic Splenocytes Treated with LPS-Induced Factors

  • R. C. Butler
  • H. Friedman
  • A. Nowotny
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 121B)

Abstract

Lipopolysaccharides (LPS) derived from gram negative bacteria are known to enhace antibody responses to a variety of antigens, including serum proteins and xenogeneic erythrocytes, both in vivo and in vitro (1,10,11). Recent studies in this laboratory have shown that such endotoxins may influence the immune response of splenocytes from Friend leukemia virus (FLV) infected mice which showed markedly impaired immune competence (2,3). The mechanism of action of LPS in enhancing antibody formation by leukemic splenocytes, as well as normal splenocytes, is still unclear. It is not known whether the LPS affects immunity by directly interacting with lymphocytes or by inducing intermediate immunoregulatory or immunostimulatory factors. In the present study attempts were made to determine whether pretreatment of mice with LPS causes the release of factors into the serum which could mediate the adjuvant effect on the in vitro antibody response of normal or leukemia virus immunosuppressed cell cultures.

Keywords

Antibody Response Spleen Cell Serratia Marcescens Muramyl Dipeptide Spleen Cell Culture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Behling, U. H., Nowotny, A. J. Immunol 118 (1977) 1905.PubMedGoogle Scholar
  2. 2.
    Butler, R. C., Nowotny, A., Friedman, H. J. Res. 22 (1977) 28a.Google Scholar
  3. 3.
    Butler, R. C., Nowotny, A., and Friedman (submitted).Google Scholar
  4. 4.
    Cunningham, A. J., Szenberg, A. Immunol. 14 (1968) 599.Google Scholar
  5. 5.
    Frank, S. J., Specter, S., Nowotny, A. and Friedman, H. J. Immunol. 119 (1977) 855.PubMedGoogle Scholar
  6. 6.
    Hoffman, M. K., Green, S., Old, L. J., and Oettgen, H. F. Nature 263 (1976) 416.CrossRefGoogle Scholar
  7. 7.
    Kamo, I., Pan, S. H., and Friedman, H. J. Immunol. Meth. 11 (1976) 5Google Scholar
  8. 8.
    Nowotny, A., Behling, U. H., Chang, H. L. J. Immunol. 115 (1975) 197Google Scholar
  9. 9.
    Nowotny, A, Cundy, K. R., Rote, N. L., Nosotny, A. M., Advuny, P. R., Thomas, S. P. and Tripodi, D. J. Ann. N. Y. Acad. Sci. 133 (1968) 586.CrossRefGoogle Scholar
  10. 10.
    Sjoberg, O., Andersson, J. and Moller, G. Europ. J. Immunol. 2 (1972) 32Google Scholar
  11. 11.
    Watson, J., Trenkner, E. and Cohn, M. J. Exp. Med., 138 (1973) 699.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • R. C. Butler
    • 1
    • 2
  • H. Friedman
    • 1
    • 2
  • A. Nowotny
    • 1
    • 2
  1. 1.Depts. of Microbiology and ImmunologyAlbert Einstein Medical Center and University of PennsylvaniaPhiladelphiaUSA
  2. 2.College of MedicineUniversity of South FloridaTampaUSA

Personalised recommendations